(
EMAILWIRE.COM, September 27, 2017 ) The Asia-Pacific Immunoassays Market was worth $ 3.29 Billion in 2016 and estimated to reach $ 5.32 Billion by the end of 2021 with a growing potential of 10.12 %. Asia-Pacific market is expected to show highest growth over the forecast period due to increasing development of new biologics, drugs, and vaccines.
Immunoassays are a
bio-chemical tests used to identify/quantify an analyte, in a blood sample, using a reaction. Immunoassays are highly specific and sensitive. Their high specificity/sensitivity results from the use of antibodies and purified analytes as a reagents. An antibody is a protein produced by immune cells in response to stimulation by an analyte. Immunoassays measure the formation of antibody-antigen complexes and identify them through an indicator reaction. High sensitivity is attained by using an indicator system that results in intensification of the measured product.
View full report @
http://www.marketdataforecast.com/market-reports/asia-pacific-immunoassays-market-1571/
The key drivers of Asia-Pacific immunoassays market are rising prevalence of infectious diseases, increasing ageing population, advancements in novel assays in various diseases such as Cardiology and oncology, growing applications in diagnosting drug monitoring tests, infectious diseases and identification of cancer biomarkers, increasing need of reagents, sensitive assays and analytical techniques, availability of wide range of reagents, introduction of novel biomarkers, growing government and corporate investment in the pharmaceutical and biotechnology segment in emerging markets. Lack of reimbursement policies, adoption of immunoassays in emerging markets, stringent regulations for storage are hampering the growth of the market.
Get free sample report @
http://www.marketdataforecast.com/market-reports/asia-pacific-immunoassays-market-1571/request-sample
Based on Technology, the market is segmented into Enzyme Immunoassay, Fluorescent Immunoassays, Cheniluminescence Immunoassays, Nephelometric Immunoassays, Radio Immunoassays, Counting Immunoassays, Turbidimetric Immunoassays, and Others. Based on Application, the market is segmented into oncology, Cancer, Hematology, Cardiology, Thyroid, Infectious diseases, Allergies and others. Based on End users, the market is segmented into Hospitals, clinics, Academic Research institute, Pharmaceutical and Biotech vendors, Laboratories and others. Based on Geography, the Asia-Pacific Immunoassays market is analysed under various regions namely China, India, Japan, South Korea, and Australia.
Inquire before buying @
http://www.marketdataforecast.com/market-reports/asia-pacific-immunoassays-market-1571/inquire
Key players influencing the Asia-Pacific Immnoassays market are Roche Diagnostics, DiaSorin S.p.A, Beckman Coulter, Siemens Healthcare, Ortho Clinical Diagnostics, bioMerieux, Thermo Fisher Scientific and Abbott Laboratories, Akers Biosciences, Inc, Becton Dickinson and Company, Devon Medical Products, EDP Biotech Corporation, Hologic (Gen-Probe), Intrinsic LifeSciences.
About Market Data Forecast:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options. For more information, kindly visit,
www.marketdataforecast.com
Market Data Forecast
Abhishek
+1-888- 702-9626
abhishek@marketdataforecast.comSource:
EmailWire.Com